Ref. SD1026·Full-time — permanent contract·Bordeaux, France
Are you an oncology and immuno-oncology scientist who enjoys turning a Sponsor's scientific objectives into robust, high-value research? Do you like steering studies from design to data interpretation, using primary immune and tumor cells, patient-derived samples, multiplex imaging, spatial biology and transcriptomics? If so, we want to hear from you! Join us and contribute to the next generation of immuno-oncology therapies.
Explicyte is a specialty oncology CRO based in Bordeaux, France, embedded at Institut Bergonié. We support academics, biotech, and pharma partners across the drug-development pipeline — from target discovery through translational studies that connect laboratory findings to clinical outcomes.
We're a human-sized team of scientists — cell biologists, immunologists, data scientists, and medical oncologists under one roof. Alongside sponsor projects we run in-house R&D and external collaborations, which have led to 30+ peer-reviewed papers over the last five years.
Our lab sits inside the Bergonié Comprehensive Cancer Center, in close contact with medical oncology teams.
As Study Director, you will lead innovative preclinical and translational research programs for our biotech and pharma Sponsors, working hand in hand with them to turn their scientific objectives into robust, high-value studies. You will provide scientific direction across the full lifecycle of each study, from design and protocol definition to data analysis, interpretation and reporting, and act as the Sponsor’s main scientific point of contact.
You will work closely with our Study Managers, who oversee day-to-day execution, and with our laboratory, imaging, spatial biology and bioinformatics teams to ensure scientific quality, consistency and timely delivery. You will report to the Chief Scientific Officer.